You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Healthy adult subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)

Recruiting
  • Healthy Adult Subjects
  • San Antonio, Texas
    ICON Early Phase Services
Oct 24, 2023

Healthy Subjects Trial in Shanghai (JYP0061, )

Completed
  • Healthy Subjects
  • Shanghai, Shanghai, China
    Shanghai Xuhui District Central Hospital
Nov 16, 2023

Psoriasis Trial in Beijing (TQH2929 injection, Placebo injection)

Recruiting
  • Psoriasis
  • TQH2929 injection
  • Placebo injection
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 27, 2023

Biliary Carcinoma Trial in Qingdao (TQB3454 tablets)

Not yet recruiting
  • Biliary Carcinoma
  • TQB3454 tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Nov 15, 2023

Chronic Hepatitis b Trial in Wuhan (TQA3038 injection, TQA3038 injection matching )

Not yet recruiting
  • Chronic Hepatitis b
  • TQA3038 injection
  • TQA3038 injection matching placebo
  • Wuhan, Hubei, China
    Tongji Hospital
Oct 17, 2023

Healthy Adult Subjects Trial in Seoul (ID110521156, Placebo of ID110521156)

Not yet recruiting
  • Healthy Adult Subjects
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Sep 26, 2023

Parkinson Disease Trial in Miami (PDM608, Placebo)

Recruiting
  • Parkinson Disease
  • Miami, Florida
    Quotient Sciences-Miami, Inc
Jul 17, 2023

Pharmacokinetics Trial in Shanghai (ZX-7101A)

Not yet recruiting
  • Pharmacokinetics
  • Shanghai, Shanghai, China
    Huashan Hospital affiliated to Fudan University
Jul 17, 2023

Healthy Trial in Lincoln (CEL383, Placebo)

Recruiting
  • Healthy
  • Lincoln, Nebraska
    Celerion
Jun 5, 2023

Chemo-induced Diarrhea Trial in Glendale (SK10, Placebo)

Recruiting
  • Chemotherapy-induced Diarrhea
  • Glendale, California
    Early Phase Clinical Unit (EPCU) - PAREXEL
Aug 30, 2023

Healthy Trial in Glendale (Y-2 Sublingual Tablet, Placebo)

Not yet recruiting
  • Healthy
  • Y-2 Sublingual Tablet
  • Placebo
  • Glendale, California
    Parexel International Los Angeles Early Phase Clinical Unit
Jul 10, 2023

Postpartum Depression Trial in Adelaide (BRII-297, Placebo)

Not yet recruiting
  • Postpartum Depression
  • Adelaide, South Australia, Australia
    CMAX
May 3, 2023

Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)

Recruiting
  • Drug Interaction
  • Beijing, Beijing, China
    Peking University Third Hospital
Sep 21, 2023

Myelofibrosis Trial in Changchun (TQ05105 Tablets)

Completed
  • Myelofibrosis
  • TQ05105 Tablets
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Aug 1, 2023

Healthy Volunteers Trial in Tempe (Epetraborole and matching , Epetraborole, Placebo)

Active, not recruiting
  • Healthy Volunteers
  • Epetraborole and matching placebo
  • +3 more
  • Tempe, Arizona
    423001
Aug 16, 2023

Healthy Trial in Nanjing (SHR8554;Itraconazole)

Completed
  • Healthy
  • Nanjing, Jiangsu, China
    Affiliated Drum Tower Hospital, Medical School of Nanjing Univer
Jun 26, 2023

Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)

Completed
  • Healthy Subjects
  • Toshima-ku, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022

Cystic Fibrosis Trial in Christchurch (ARCT-032, Placebo)

Not yet recruiting
  • Cystic Fibrosis
  • Christchurch, New Zealand
    New Zealand Clinical Research
Feb 3, 2023

Acromegaly Trial in Beijing (SYHX2008 injection, Octreotide Acetate Microspheres for Injection injection, Sandostatin ®

Recruiting
  • Acromegaly
  • SYHX2008 injection
  • +3 more
  • Beijing, Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Mar 13, 2023

Healthy Male Subjects Trial in Tokyo ([14C] TS-142)

Completed
  • Healthy Male Subjects
  • [14C] TS-142
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets)

Completed
  • Paroxysmal Nocturnal Hemoglobinuria
  • MY008211A tablets
  • Changsha, Hunan, China
    The Third Hospital of Changsha
Apr 13, 2023

Healthy Subjects Trial in Tokyo (TS-142, Itraconazole)

Completed
  • Healthy Subjects
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022

Healthy Trial in Mahesana (Omalizumab 150mg)

Recruiting
  • Healthy
  • Omalizumab 150mg
  • Mahesana, Gujarat, India
    Registered BE centre
Nov 4, 2022

Healthy Trial (DWP213388, Placebo)

Not yet recruiting
  • Healthy
  • (no location specified)
Nov 1, 2022

Atopic Dermatitis Trial in Changsha (QLM3003, QLM3003 Placebo)

Recruiting
  • Atopic Dermatitis
  • Changsha, Hunan, China
    The Third Xiangya Hospital of Central South University
Jul 2, 2023